Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic

This study uses commercial and Medicare Advantage claims data to compare medication fills, outpatient visits, and urine tests for opioid use disorder in January-May 2020 vs 2019.

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA
Main Authors: Huskamp, Haiden A., Busch, Alisa B., Uscher-Pines, Lori, Barnett, Michael L., Riedel, Lauren, Mehrotra, Ateev
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Research Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7739126/
https://ncbi.nlm.nih.gov/pubmed/33320214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.21512
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares